HFYRX
Price
$15.57
Change
+$0.14 (+0.91%)
Updated
Jul 2 closing price
Net Assets
3.57B
VIHAX
Price
$47.97
Change
+$0.74 (+1.57%)
Updated
Jul 2 closing price
Net Assets
20.46B
Interact to see
Advertisement

HFYRX vs VIHAX

HFYRX vs VIHAX Comparison Chart in %
View a ticker or compare two or three
VS
HFYRX vs. VIHAX commentary
Jul 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFYRX is a Hold and VIHAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIHAX has more cash in the bank: 20.5B vs. HFYRX (3.57B). VIHAX pays higher dividends than HFYRX: VIHAX (3.63) vs HFYRX (2.24). HFYRX was incepted earlier than VIHAX: HFYRX (10 years) vs VIHAX (10 years). HFYRX (1.46) is less costly to investors than VIHAX (0.16). HFYRX is a more actively managed with annual turnover of: 120.00 vs. VIHAX (9.00). HFYRX has a lower initial minimum investment than VIHAX: HFYRX (0) vs VIHAX (3000). HFYRX annual gain was more profitable for investors over the last year : 29.95 vs. VIHAX (24.00). HFYRX return over 5 years is better than : 69.19 vs. VIHAX (54.17).
HFYRXVIHAXHFYRX / VIHAX
Total Expense Ratio1.460.16913%
Annual Report Gross Expense Ratio1.460.16913%
Fund Existence10 years10 years-
Gain YTD16.04010.831148%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.57B20.5B17%
Annual Yield % from dividends2.243.6362%
Returns for 1 year29.9524.00125%
Returns for 3 years80.3261.58130%
Returns for 5 years69.1954.17128%
Returns for 10 yearsN/A107.66-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRHSX91.922.19
+2.44%
T. Rowe Price Health Sciences
ICERX54.970.99
+1.83%
NYLI Epoch International Chc SIMPLE Cl
IEVAX14.100.13
+0.93%
Columbia Global Value A
WCMNX15.64-0.15
-0.95%
WCM Small Cap Growth Investor
HISVX53.18-1.35
-2.48%
Harbor Small Cap Value Investor